Pharmacotherapy for sexual dysfunction in women

Bibliography

• KONTULA 0, HAAVIO-MANNILA E: Sexual pleasures. Enhancement of sex life in Finland. Brookfield VT (Ed.), Dartmouth Publishing Co., Aldershot, Hants, England (1995):1971–1992.
   Google Scholar
• HAWTON K, GATH D, DAY A: Sexual function in a community sample of middle-aged women with partners. Effects of age, marital, socio-economics, psychiatric, gynecological and menopausal factors. iArch. Sex. Behav. i (1995) 23:375–395.
   Google Scholar
• VENTEGODT S: Sex and the quality of life in Denmark. iArch. Sex. Behav i (1998) 27:295–307.
   PubMed Web of Science ®Google Scholar
• FISHER WA, BORODITSKY R, BRIDGES M: Measures of sexual and reproductive health among Canadian women. iCan. I Human Sexuality i (1999) 8(3):175–182.
   Google Scholar
• FUGL-MEYER AR, SJOGREN FUGL-MEYER K: Sexual disabilities, problems and satisfaction in 18 to 74-year-old Swedes. iScand. J. Sexology i (1999) 2(2):79–105.
   Google Scholar
• •One of the better epidemiological studies including older women.
   Google Scholar
• LAUMANN EL, PAIK A, ROSEN RC: Sexual dysfunction in United States: prevalence and predictors. iJ. Am. Med. Assoc. i (1999) 10:537–545.
   Web of Science ®Google Scholar
• CAIN VS, JOHANNES CB, AVIS NE iet al.: i Sexual functioning and practices in a multi-ethnic study of midlife women: baseline results from SWAN. iSex Res. i (2003) 40(3):266–276.
   Google Scholar
• •Clear evidence that having sexual desire may be of little relevance to women's sexual motivation. First publication with regard to baseline sexual function of a cohort of women of different ethnic backgrounds, to be studied longitudinally.
   Google Scholar
• MONTEJO AL, LLORCA G, IZQUIERDO JA, RICO-VILLADEMOROS F: Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicentre study of 1022 outpatients. iClin. Psych. i (2000) 162\(Suppl. 3):10–21.
   Google Scholar
• HILL CA, PRESTON LK: Individual differences in the experience of sexual motivation: theory and measurement of dispositional sexual motives. " iSex. Res. i (1996) 33(1):27–45.
   Google Scholar
• GALYER KT, CONAGLEN HM, HARE A, CONAGLEN JV: The effect of gynecological surgery on sexual desire.' iSex Marital Ther. i (1999) 25:81–88.
   PubMed Web of Science ®Google Scholar
• SCHULTZ WCM, VAN DE WIEL HBM, HAHN DEE: Psychosexual functioning after treatment for gynecological cancer an integrated model, review of determinant factors and clinical guidelines. ihat. J. Cynecol Cancer i (1992) 2:281–290.
   PubMed Web of Science ®Google Scholar
• REGAN P, BERSCHEID E: Belief about the state, goals and objects of sexual desire. i.1. Sex. Marital Ther. i (1996) 22:110–120.
   PubMed Web of Science ®Google Scholar
• KLUSMANN D: Sexual motivation and the duration of partnership. iArch. Sex. Behav i (2002) 31(3):275–287.
   PubMed Web of Science ®Google Scholar
• BASSON R: Female sexual response: The role of drugs n the management of sexual dysfunction. iObstet. Cynecol i (2001) 98:350–353.
   Google Scholar
• American Psychiatric Association. DSM-IVTR: Diagnostic and statistical manual for mental disorders (4th edn). American Psychiatric Press, Washington, DC, USA (2000).
   Google Scholar
• LAAN E, VAN DRIEL E, VAN LUNSEN RHW: Seksuele reakties van vrouwen met een seksuele opwindingsstoornis op visuele seksuele stimuli [Sexual responses of women with sexual arousal disorder to visual sexual stimuli]. iTilt/schrift voor Seksuologie i (2003) 27:1-13. (Also submitted to iAm. J. i Psychiatri).
   Google Scholar
• BASSON R, LEIBLUM S, BROTTO iet al: iDefinitions of women's sexual dysfunction reconsidered: advocating expansion and revision. iJ. Psychosom. Obstet. Cynecol i (2003) 24:221–229.
   PubMed Web of Science ®Google Scholar
• •Publication of an International Committee's 2-year deliberation on definitions, which accurately reflect healthy sexual function as well as dysfunction in women. The evidence and rationale for the proposed changes are given plus recognition that further changes are expected after greater clinical use and formal validation studies.
   Google Scholar
• BASSON R, BERMAN J, BURNETT A iet al.: i Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. iUrol i (2000) 163:888–893.
   Google Scholar
• LAAN E, EVERAERD W: Determinants offemale sexual arousal: Psychophysiological theory and data. iAnn. Rev Sex Res. i (1995) 6:32–76.
   Google Scholar
• •Key paper on a basic psychophysiological study of sexual arousal in women.
   Google Scholar
• SHIFREN JL, BRAUNSTEIN GD, SIMON JA iet al.: i Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. iN Engl. J. Med. i (2000) 343(10):682–688.
   Google Scholar
• SEGRAVES T: Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. iJ. Clin. Psychopharmacol i (In Press).
   Google Scholar
• KARAMA S, LECOURS AR, LEROUX JM iet al.: i Areas of brain activation in males and females during viewing of erotic film excerpts. iHum. Brain Mapp. i (2002) 16:1–13.
   Google Scholar
• MANI SK, ALLEN JMC, CLARK JH, BLAUSTEIN JD, O'MALLEY BW: Convergent pathways for steroid hormone-and neurotransmitter-induced rat sexual behaviour. iScience i (1995) 265:1246–1248.
   Google Scholar
• BLAUSTEIN JD: Progestin receptors: neuronal integrators of hormonal and environmental stimulation. iAnn. NY Acad. Sci i (2003) 1007:1–13.
   Web of Science ®Google Scholar
• DENNERSTEIN L, LEHERT P, GUTHRIE J: The effects of the menopausal transition and biopsychosocial factors on well-being. iArch. Women Merit. Health. i (2002) 5:15–22.
   PubMedGoogle Scholar
• CAWOOD EHH, BANCROFT J: Steroid hormones, the menopause, sexuality and well being of women. iPsycho]. Med. i (1996) 26:925–936.
   Google Scholar
• DENNERSTEIN L, RANDOLPH J, TAFFE J, DUDLEY E, BURGER H: Hormones, mood, sexuality, and the menopausal transition. iFeral. Steril i (2002) 77:S42–S48.
   PubMed Web of Science ®Google Scholar
• CONAGLEN HM, CONAGLEN JV: Sexual desire in women presenting for antiandrogen therapy." iSex Marital Tiler. i (2003) 29(4):255–267.
   Google Scholar
• BASSON R, WEIJMAR SCHULTZ CM, BROTTO L iet al.: i Second international consultation on sexual medicine: men and women's sexual dysfunction. Paris: Health Publications Limited, 2004.
   Google Scholar
• ••Currently in press, this major work of> 100 authors will be available to all on the web as well as in two volumes. The chapter on women's sexual desire, arousal, and sexual pain is very detailed and biopsychosocial in its approach. All chapters are evidenced based.
   Google Scholar
• SHERWIN BB, GELFAND MM, BRENDER W: Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. iPsychosom. Med. i (1985) 47(4):339–351.
   PubMed Web of Science ®Google Scholar
• BURGER HG, HAILES J, MENELAUS M: The management of persistent symptoms with estradiol-testosterone implants: clinical, lipid and hormonal results. iMaturitas i (1984) 6:351–358.
   PubMed Web of Science ®Google Scholar
• BURGER HG, HAILES J, NELSON J, MENELAUS M: Effect of combined implants of estradiol and testosterone on libido in postmenopausal women. iBr. Med. i (1987) 294:936–937.
   PubMed Web of Science ®Google Scholar
• DAVIS SR, MCCLOUD P, STRAUSS BJG, BURGER H: Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. iMaturitas (1995) i 21(3):227–236.
   Google Scholar
• SARREL P, DOBAY B, WIITA B: Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. sexual behaviour and neuroendocrine response. iReprod. Med. i (1998) 43(10):847–856.
   Google Scholar
• FLOTER A, NATHORST- BOOS J, CARLSTROM K, VON SCHOULTZ B: Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well being. iClimacteric i (2002) 5:357–365.
   PubMed Web of Science ®Google Scholar
• BARRETT-CONNOR E: Efficacy and safety of estrogen/androgen therapy: menopausal symptoms, bone land cardiovascular parameters.' iReprod. Med. i (1998) 43:746–752.
   PubMed Web of Science ®Google Scholar
• LOBO RA, ROSEN RC, YANG HM, BLOCK B, VAN DER HOOP RG: Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. iFertil. Steil]. i (2003) 79(6):1341–1352.
   PubMed Web of Science ®Google Scholar
• LABRIE F, LUU-THE V, LABRIE C iet al.: i Endocrine sources of androgens in women: Inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. iEndocrine Rev (2003) i 24:152–182.
   Google Scholar
• ••An extremely important review of thelimited value of measuring serum levels of testosterone or its precursors.
   Google Scholar
• ROSSOUW JE, ANDERSON GL, PRENTICE RL iet al.: i Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. iJAMA i (2002) 288(3):321–333.
   Google Scholar
• Million women study collaborators. BreastCancer and hormone replacement therapy in the million women study. iLancet i (2003) 362:419–427.
   PubMed Web of Science ®Google Scholar
• ARLT W, CALLIES F, VAN VLIJMEN JC iet al.: i Dehydroepiandrosterone replacement in women with adrenal insufficiency. iN Engl. I Med. i (1999) 341(14):1013–1020.
   Google Scholar
• LOOVAS K, GEBRE-MEDHIN G, TROVIK TS iet al.: i Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month randomized parallel group clinical trial. I. Clin. iEndocrinol Metab. i (2003) 3:1112–1118.
   Google Scholar
• HUNT P, GURNELL E, HUPPERT F: Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison 's disease in a randomized, double blind trial. I. iClin. Endocrinol Metab. i (2000) 85:4650–4656.
   PubMed Web of Science ®Google Scholar
• BARNHART K, FREEMAN E, GRISSO JA iet al.: i The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. iEndocrinol Metab. i (1999) 84(11):3896–3902.
   Google Scholar
• BAULIEU E, THOMAS G, LEGRAIN S, ROGER M, DEBUIRE B, FAUCOUNAU V: Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution to the DHEAge study to a sociobiomedical issue. iProc. Nat. Acad. Sci. i USA (2000)97(8):4279–4284.
   PubMed Web of Science ®Google Scholar
• SIMONCINI T, MANELLA P, FORNARI L, VARONE G, CARUSO A, GENAZZANI AR: Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. iEndocrinology i (2003)144(8):3449–3455.
   PubMed Web of Science ®Google Scholar
• MESTON CM, HEIMAN JR: Acute dehydroepiandrosterone effects on sexual arousal in premenopausal women. iSex. Marital Ther. i (2002) 28:53–60.
   PubMed Web of Science ®Google Scholar
• WALLEN K: Sex and context: Hormones and primate motivation. iHormones Behav. i (2002) 40:339–357.
   Web of Science ®Google Scholar
• BURNETT Al, CALVIN TC, SILVER RI, PEPAS DS, DOCIMO SG: Immuno-chemical description of nitric oxide synthase isoforms in human clitoris. iUrol. i (1997) 158 (75):278.
   Google Scholar
• TRAISH AM, KIM NN, MUNARRIZ R, MORELAND R, GOLDSTEIN I: Biochemical and physiological mechanisms of female genital sexual arousal. iArch. Sex. Behav i (2002) 31(5):393–400.
   PubMed Web of Science ®Google Scholar
• O'CONNELL HE, HUTSON JM, ANDERSON CR, PLENTER RJ: Anatomical relationship between urethra and clitoris. iUrol i (1998) 159:1892–1897.
   PubMed Web of Science ®Google Scholar
• ZIESSEN T, MONCADA S, CELLEK S: Characterization of the non-nitrergic NANC relaxation responses in the rabbit vaginal wall. iBr. Pharmacol i (2002) 135:546–554.
   PubMed Web of Science ®Google Scholar
• OTTESEN B, PEDERSEN B, NEILSEN J, DALGAARD D, WAGNER G, FAHRENKRUG J: Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women. iPeptides i (1987) 8:797–800.
   PubMed Web of Science ®Google Scholar
• BROTTO L, BASSON R, GORZALKA B: Psychophysiological assessment in premenopausal sexual arousal disorder. iSex. Med. i (In Press).
   Google Scholar
• TADDEI S, VIRDIS A, GHIADONI L iet al.: i Menopauses associated with endothelial dysfunction in women. iHypertension i (1996) 28:576–582.
   Google Scholar
• MENDELSOHN ME, KARAS RH: The protective effects of oestrogen on the cardiovascular system. iN Engl. Med. i (1999) 340:1801–1811.
   PubMed Web of Science ®Google Scholar
• GERHARD M, WALSH BW, TAWAKOL A iet al: i Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. iCirculation i (1998) 98:1158–1163.
   PubMed Web of Science ®Google Scholar
• LAAN E, VAN LUNSEN RHW: Hormones and sexuality in postmenopausal women: A psychophysiological study. iPsychom. °Enter Cynecol i (1997) 18:126–133.
   Google Scholar
• MARAVILLA KR, HEIMAN JR, GARLAND PA iet al.: i Dynamic MR imaging of the sexual arousal response in women. iSex Marital Ther. i (2003) 29\(Suppl. 1):71–76.
   Google Scholar
• MARIN R, ESCRIG A, ABREU P, MAS M: Androgen-dependent nitric oxide release in rat penis correlates with levels of
   Google Scholar
• •• constitutive nitric oxide synthase isoenzymes. iBiol. Reprod. (1999) i 61:1012.
   Google Scholar
• CARUSO S, INTELISANO G, LUPO L, AGNELLO C: Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, crossover, placebo-controlled study. iBr. J. Obstet. Gynecol i (2001) 108:623–628.
   Google Scholar
• BASSON R, MCINNES R, SMITH MD, HOD GSON G, KOPPIKER N: Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal. iGend. Based Med. i (2002) 11(4):367–377.
   Google Scholar
• BERMAN JR, BERMAN LA, TOLLER SM, GILL J, HAUGHIE S: Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: A double-blind, placebo-controlled study. iUrol. i (2003) 170:2333–2338.
   PubMed Web of Science ®Google Scholar
• BASSON R, BROTTO L: Sexual psychophysiology and effects of sildenafil citrate in oestrogenized women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. iNOG i (2003) 110:1014–1024.
   Google Scholar
• •A documentation of heterogeneity of acquired genital arousal disorder, suggesting ongoing difficulties with assessing drug treatment unless some measure of sexually stimulated genital congestion is included. Also highlighted is the need to investigate the pathophysiology of reduced sexual sensitivity of physiologically engorged tissue.
   Google Scholar
• LAAN E, VAN LUNSEN RHW, EVERAERD W, RILEY A, SCOTT E, BOOLELL M: The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women. iJ. Women' Health Gend. Based Med. i (2002) 11(4):357–365.
   PubMedGoogle Scholar
• ••An interesting documentation of increasedsubjective sexual arousal when believing to be, rather than being, on active drug, despite the active drug actually increasing the genital congestion.
   Google Scholar
• CASTELO-BRANCO C, VICENTE JJ, FIGUERAS F iet al.: i Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. iMaturitas i (2000) 34:161–168.
   Google Scholar
• LAAN E, VAN LUNSEN RH, EVERAERD W: The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. iClimacteric i (2001) 4:28–41.
   PubMedGoogle Scholar
• •Level I clinical and laboratory based evidence with regard to sexual benefits with tibolone plus a discussion of different neural pathways for different modalities of sexual stimulation.
   Google Scholar
• MEND OZA N, SUAREZ AM, ALAMO F,BARTUAL E, VERGARA F, HERRUZO A: Lipid effects, effectiveness and acceptability of tibolone versus transdermic 17 13 estradiol for hormonal replacement therapy in women with surgical menopause. iMaturitas i (2000) 37:37–43.
   PubMed Web of Science ®Google Scholar
• GERBER S, BONGIOVANNI AM, LEDGER WJ, WITKIN SS: Interleukin-1 beta gene polymorphism in women with vulvar vestibulitis syndrome. iEar. Obstet. Gynecol Reprod. Biol. i (2003) 104:74–77.
   Google Scholar
• GERBER S, BONGIOVANNI AM, LEDGER WJ, WITKIN SS: Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. iAm. J. Obstet. Gynecol i (2002) 186:696–700.
   PubMed Web of Science ®Google Scholar
• JEREMIAS J, LEDGER WJ, WITKIN SS:Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am. iObstet. Gynecol i (2000) 182:283–285.
   PubMed Web of Science ®Google Scholar
• BROTTO L, BASSON R, GEHRING D: 'Psychological profiles among women with vulvar vestibulitis syndrome: A Chart iReview'. i j iPsychosom. Obstet. Gynecol i (2003) 24:3.
   Web of Science ®Google Scholar
• HARLOW BL, STEWART EG: The population-based assessment of chronic unexplained vulval pain: have we underestimated the prevalence of vulvodynia? I iMed. Worn. Assoc. i (2003) 58:82–88.
   PubMedGoogle Scholar
• ••The first of possibly many publicationsstemming from an NIH grant to address VVS, which clarifies that this is not rare in non-Caucasians and is highly prevalent. Affiliation Rosemary Basson MD, FRCP(UK) Clinical Professor, UBC Departments of Psychiatry and Obstetrics & Gynaecology, B.C. Centre for Sexual Medicine, Vancouver General Hospital, 855 West 12th Avenue, Vancouver, BC, Canada V5Z 1M9 Tel: +1(604) 875 8254; Fax: +1(604) 875 8249; E-mail: [email protected]
   Google Scholar